Stephanie Fradette

Company: Biogen Idec

Job title: Senior Director - Medical & Clinical Development

Seminars:

Showcasing Clinical Findings for Toferson: Disease-Modifying Capabilities Targeting SOD1 Genetic Mutation 8:30 am

• Explaining ongoing clinical strategy in extended phase 3 clinical trials • Outlining lessons learnt regarding clinical endpoints from interactions with regulatory authorities • What is the future for therapies targeting familial ALS seeking approval?Read more

day: Day One AM